Intended exclusively for in vitro laboratory applications and may not be: Utilized in clinical or investigational studies Applied in any medical, therapeutic, or diagnostic setting Incorporated into products intended for consumer distribution Distributed for purposes outside regulated laboratory research Availability: 23 in stock Go card-less with Wallid Use online banking
Oral Administration (Pentadeca Arginate Capsules/Liquid) How it Works: Taken orally, the peptide has a strong first-pass effect on the gut and liver
Key pathophysiologic mechanisms include: Mucosal barrier dysfunction: Impaired epithelial tight junctions allow bacterial translocation, triggering innate immune activation T-helper cell dysregulation: Predominantly Th1 and Th17 pathways drive chronic inflammation via TNF-, IL-12, IL-23 the basis for biologic therapy targets Transmural inflammation: Unlike UC (mucosal only), CD involves all layers: mucosa submucosa muscularis propria serosa Granuloma formation: Non-caseating granulomas are pathognomonic but present in only ~3050% of biopsies Fibrosis and stricture: Chronic inflammation activates myofibroblasts collagen deposition luminal narrowing obstructive symptoms Fistula formation: Transmural ulcers penetrate serosa form sinus tracts connect to adjacent bowel, bladder, vagina, or skin 7
PRP can be useful in selected patients when the protocol is consistent
It is important in the maintenance of our metabolism, blood cells, and nerve function
